A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Three Fixed Doses (100 Mg, 200 Mg, Or 400 Mg) Of DVS-233 SR In Adult Outpatients With Major Depressive Disorder
收藏DataCite Commons2025-11-24 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006809/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To compare the antidepressant efficacy and safety of subjects receiving DVS-233 SR versus
subjects receiving placebo.
提供机构：
Vivli
创建时间：
2021-04-02
